Korea FDA Posts Names Of Companies Approved For Bioequivalence Tests
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Stepping back from its earlier harsh stance on local generic pharmaceutical makers, Korea FDA said it is now posting each week the names of local generic makers that successfully obtain approvals for bioequivalence tests, which compare the bio-availability of generics to original products